Combination Treatment with Hepatitis C Virus Protease and NS5A Inhibitors Is Effective against Recombinant Genotype 1a, 2a, and 3a Viruses

Judith M. Gottwein, Sanne B. Jensen, Yi-Ping Li, Lubna Ghanem, Troels K. H. Scheel, Stéphanie B. N. Serre, Lotte Mikkelsen, Jens Bukh
  • Antimicrobial Agents and Chemotherapy, December 2012, ASM Journals
  • DOI: 10.1128/aac.02164-12

The authors haven't yet claimed this publication.

Read Publication

In partnership with: